<?xml version="1.0" encoding='utf-8' ?>
<nspnews type="text">
<version>v8.0</version>
<date>2024-06-19 16:50:41</date>
<action>I</action>
<registdate>2024-06-19 16:19:22</registdate>
<modifydate>2024-06-19 16:39:39</modifydate>
<publishdate>2024-06-19 16:50:36</publishdate>
<embargo>N</embargo>
<newsid>704149</newsid>
<orgid></orgid>
<language>KR</language>
<category1>21</category1>
<category2>2102</category2>
<category1_name>의학/건강</category1_name>
<category2_name>제약/바이오</category2_name>
<statusID>1</statusID>
<saleID>N</saleID>
<formatID>1</formatID>
<typeID>9</typeID>
<newsSubject><![CDATA[[업앤다운]제약주 상승…옵투스제약↑·플럼라인생명과학↓]]></newsSubject>
<newsSummary><![CDATA[]]></newsSummary>
<newsTag><![CDATA[옵투스제약(131030),플럼라인생명과학(222670),제약주,코스피,코스닥]]></newsTag>
<newsLinks><![CDATA[]]></newsLinks>
<news_prolog><![CDATA[(서울=NSP통신) 이복현 기자 =]]></news_prolog>
<news1><![CDATA[19일 코스피(+1.21%)와 코스닥(+0.26%)이 모두 상승한 가운데 제약주(+1.71%)도 상승했다. 상승주는 52개였고 하락주는 113개였다.

오늘 제약주 중에서는 옵투스제약의 상승률이 가장 높았다. 옵투스제약은 전일대비 19.27%(1220원) 올라 7550원에 장을 마감했다. 옵투스제약은 2거래일연속 상승했다.

또 삼천당제약(+15.76%) 엔솔바이오사이언스(+11.51%) 보로노이(+8.56%) 대동고려삼(+7.47%) 인벤티지랩(+7.08%) 큐리언트(+4.95%) 큐라클(+4.42%) 비피도(+3.78%) 압타바이오(+3.45%) 삼일제약(+3.19%) 등이 상승했다.

반면 플럼라인생명과학(코넥스)의 하락률이 높았다. 플럼라인생명과학은 전일대비 12.31%(720원) 내려 5130원에 장을 마감했다. 플럼라인생명과학은 지난 10일(보합)부터 하락세(17일 보합)를 이어오고 있다. 

또 티움바이오(-7.14%) 신풍제약(-6.40%) 퓨쳐메디신(-5.07%) 에이디엠코리아(-4.72%) 퓨쳐켐(-4.21%) 아이큐어(-4.09%) 휴럼(-3.85%) 에이프로젠바이오로직스(-3.79%) 녹십자웰빙(-3.39%) 동국제약(-3.39%) 뉴트리(-3.33%) 등이 하락했다.]]></news1>
<news2_title><![CDATA[]]></news2_title>
<news2><![CDATA[]]></news2>
<news3_title><![CDATA[]]></news3_title>
<news3><![CDATA[]]></news3>
<news4_title><![CDATA[]]></news4_title>
<news4><![CDATA[]]></news4>
<news5_title><![CDATA[]]></news5_title>
<news5><![CDATA[]]></news5>
<news_epilog_info><![CDATA[]]></news_epilog_info>
<news_epilog_byline><![CDATA[NSP통신 이복현 기자(bhlee2016@nspna.com)]]></news_epilog_byline>
<news_epilog><![CDATA[ⓒ한국의 경제뉴스통신사 NSP통신·NSP TV. 무단전재-재배포 및 AI학습 이용 금지.]]></news_epilog>
<imageL><![CDATA[https://file.nspna.com/news/2024/06/19/20240619162206_704149_0.jpg]]></imageL>
<imageP><![CDATA[https://file.nspna.com/news/2024/06/19/photo_20240619162206_704149_0.jpg]]></imageP>
<image1><![CDATA[https://file.nspna.com/news/2024/06/19/20240619162206_704149_1.jpg]]></image1>
<image2><![CDATA[]]></image2>
<image3><![CDATA[]]></image3>
<image4><![CDATA[]]></image4>
<image5><![CDATA[]]></image5>
<image1_place><![CDATA[l]]></image1_place>
<image2_place><![CDATA[c]]></image2_place>
<image3_place><![CDATA[c]]></image3_place>
<image4_place><![CDATA[c]]></image4_place>
<image5_place><![CDATA[c]]></image5_place>
<image1_text><![CDATA[]]></image1_text>
<image2_text><![CDATA[]]></image2_text>
<image3_text><![CDATA[]]></image3_text>
<image4_text><![CDATA[]]></image4_text>
<image5_text><![CDATA[]]></image5_text>
<image1_source><![CDATA[이미지 = 옵투스제약]]></image1_source>
<image2_source><![CDATA[]]></image2_source>
<image3_source><![CDATA[]]></image3_source>
<image4_source><![CDATA[]]></image4_source>
<image5_source><![CDATA[]]></image5_source>
<vodSite><![CDATA[]]></vodSite>
<vodID><![CDATA[]]></vodID>
<vodTitle><![CDATA[]]></vodTitle>
<vodWidth><![CDATA[]]></vodWidth>
<vodHeight><![CDATA[]]></vodHeight>
<advertorial><![CDATA[]]></advertorial>
<location><![CDATA[서울]]></location>
<teamID>107</teamID>
<teamName><![CDATA[의학건강부]]></teamName>
<writerID>bhlee2016</writerID>
<writerName><![CDATA[이복현]]></writerName>
<writerTitle><![CDATA[기자]]></writerTitle>
<writerEmail><![CDATA[bhlee2016@nspna.com]]></writerEmail>
<writerID2></writerID2>
<writerName2><![CDATA[]]></writerName2>
<writerTitle2><![CDATA[]]></writerTitle2>
<writerEmail2><![CDATA[]]></writerEmail2>
<writerID3></writerID3>
<writerName3><![CDATA[]]></writerName3>
<writerTitle3><![CDATA[]]></writerTitle3>
<writerEmail3><![CDATA[]]></writerEmail3>
</nspnews>
